Biotech Target N V - Oct 19, 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/Daniel Koller
Stock symbol: MGNX
Transactions as of: Oct 19, 2022
Transactions value $: $1,767,484
Form type: 4
Date filed: 10/21/2022, 03:03 PM
Previous filing: Aug 30, 2022
Next filing: Oct 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Purchase	$624K	+168K	+2.31%	$3.70	7.44M	Oct 19, 2022	Direct
transaction	MGNX	Common Stock	Purchase	$1.14M	+286K	+3.84%	$4.00	7.73M	Oct 20, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.